Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Hepatocellular carcinoma and Enhancer, with related work in Cancer research, KEGG, Immune system. Notable publications include 'A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2', 'IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer', and 'Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure'.
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure
Low expression of AQP9 and its value in hepatocellular carcinoma
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics
A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2
A super-enhancer maintains homeostatic expression of Regnase-1